Latest news
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Average Recommendation of "Reduce" from Analysts - MarketBeatMarketBeat · Tue, 11 Aug 2026 10:34:21 GMTAMPH Q2 Deep Dive: Portfolio Expansion and Pipeline Progress Drive Results - Yahoo FinanceYahoo Finance · Tue, 11 Aug 2026 08:13:22 GMTWeekly Recap: Amphastar Q2 growth, $100M BAQSIMI and IMS FDA warning - TradingViewTradingView · Mon, 10 Aug 2026 11:37:13 GMTAmphastar Pharmaceuticals (NASDAQ:AMPH) Upgraded by Wall Street Zen to "Strong-Buy" Rating - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:21:23 GMTAmphastar Pharmaceuticals (AMPH) Stock Rebound Meets Margin Pressure And Valuation Gap - simplywall.stsimplywall.st · Sat, 08 Aug 2026 01:11:15 GMTAmphastar Pharmaceuticals, Inc. SEC Filing (Aug 7, 2026) - Stock TitanStock Titan · Fri, 07 Aug 2026 20:09:42 GMTAmphastar Pharmaceuticals (NASDAQ:AMPH) Price Target Cut to $20.00 by Analysts at Piper Sandler - MarketBeatMarketBeat · Fri, 07 Aug 2026 17:02:18 GMTWells Fargo & Company Increases Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $20.00 - MarketBeatMarketBeat · Fri, 07 Aug 2026 14:54:55 GMT